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Abstract. Background. Tuberous sclerosis is an uncommon neurocutaneous syndrome characterized by the 
appearance of hamartomas in multiple organs. Diagnosis is based on clinical criteria.
Objective. To report the clinical findings in a series of 67 patients with tuberous sclerosis.
Material and methods. This was a descriptive and observational retrospective study of patients with tuberous 
sclerosis referred to our dermatology clinics between January 1994 and March 2007.
Results. All patients presented neurological or dermatological disorders. Other disorders, in descending 
frequency, were psychiatric (55.5 %), renal (32.8 %), cardiac (22.4 %), skeletal and pulmonary (13.4 %), and 
ophthalmological (11.9 %).
Conclusions. We report the clinical findings in a series of patients with tuberous sclerosis. According to our 
literature search, this is the first such study in the Spanish population. Overall, our findings support those 
already published.
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EsclErosis tubErosa. Hallazgos clínicos En 67 paciEntEs
Resumen. Introducción. La esclerosis tuberosa (ET) es un síndrome neurocutáneo infrecuente caracterizado 
por la aparición de hamartomas en múltiples órganos. Su diagnóstico se basa en criterios clínicos.
 Objetivo. Describir los hallazgos clínicos en una serie de 67 pacientes afectos de ET.
 Material y métodos. Llevamos a cabo un estudio retrospectivo, descriptivo y observacional de los pacientes con 
ET remitidos a nuestras consultas de Dermatología entre enero de 1994 y marzo de 2007.
 Resultados. El 100 % de los pacientes presentaron alteraciones neurológicas o dermatológicas. El resto fueron, 
por orden: psiquiátricas (55,5 %), renales (32,8 %), cardíacas (22,4 %), esqueléticas y pulmonares (13,4 %) y 
 oftalmológicas (11,9 %).
 Conclusiones. Describimos los hallazgos clínicos en una serie de pacientes afectos de ET. Se trata, según la lite-
ratura revisada, del primer estudio de este tipo en la población española. Globalmente, nuestros datos apoyan lo 
hasta ahora publicado.
Palabras clave: esclerosis tuberosa, manifestaciones dermatológicas, manifestaciones neurológicas.
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introduction
Tuberous sclerosis (TS) is a neurocutaneous syndrome 
with an autosomal dominant inheritance pattern and 
is characterized by the appearance of hamartomas in 
multiple organs. The classic clinical triad consists of 
angiofibromas, mental retardation, and epilepsy; however, 
these only appear in 29% of the patients and 6% do 
not present any such characteristics.1 The incidence of 
TS is estimated to range between 1:5800 and 1:10 000 
and in two-thirds of the patients TS is due to sporadic 
mutations.2 Two genes responsible for the disease have 
been identified: TSC1 on chromosome 9 and TCS2 on 
chromosome 16.3 The enormous clinical variability of TS 
is explained by mutations on these genes and mosaicisms, 
as well as variable penetrance. The diagnosis of TS is 
principally clinical and is based on a series of criteria (Table 
1), since there is no single diagnostic finding.4 Morbidity 
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and mortality in TS are usually related to neurological 
manifestations.2
In this study, we report the findings in a series of 67 
patients and compare our results to those of the reviewed 
literature.
Material and Methods
This was a descriptive and retrospective, observational 
study of the patients with TS referred to our dermatology 
clinics between January 1994 and March 2007. All 
the patients who fulfilled a definitive diagnosis of TS 
according to the diagnostic criteria (Table 1) were 
included in the study. Patient data were extracted from 
an Excel spreadsheet, supplemented by their medical 
records and any ophthalmological, neurological, and 
psychiatric studies, etc, undergone by patients. Patient 
age, sex, and family history of TS were recorded. Any 
associated disorder was recorded and classified as follows: 
dermatological disorders, cardiac disease, central nervous 
system (CNS) disease, psychiatric disorders, renal, 
skeletal, and respiratory disorders, and ophthalmological 
disorders.
Skin manifestations were studied in greater detail, as 
follows:
1.  Angiofibromas were classified according to their 
location on the face (cheeks, nose, nasogenian fold 
and forehead), their pattern of presentation (crazy 
paving or sebaceous), and distribution (unilateral or 
bilateral) (Figure). The sebaceous pattern is defined as 
the appearance of isolated lesions, separated from each 
other, and the crazy paving pattern when lesions form a 
patch with multiple lobulations on its surface.
2.  Hypomelanotic macules were classified into 4 groups: 
lanceolate or ash-leaf shaped, confetti pattern, 
fingerprint-shaped, and other (none of the 3 previous 
groups). In addition, their location on the anterior 
thorax, posterior thorax, arm, leg, and abdomen was 
taken into account.
3.  If Koenen tumors were present, it was noted whether 
they appeared on the hands or feet. Shagreen or 
sharkskin patches were also classified according to their 
location.
results
A total of 67 patients (35 women and 32 men) were 
included, with a mean age of 27.61 years (range, 15 to 
80 years). There was a family history of TS in 21%. The 
results are summarized in Table 2. All patients presented 
dermatological disorders; of these, the most frequent 
table 1. Diagnostic Criteria for Tuberous Sclerosis4
Major Criteria Developmental Age
Angiofibromas or plaque on the 
forehead
Childhood‑adult
Nontraumatic periungual fibromas Adolescent‑adult
Hypomelanotic macules (3 or more) Childhood‑adult
Shagreen patch (connective‑tissue 
nevus)
Childhood
Multiple retinal hamartomas Childhood
Cortical tubers Fetal stage
Subependymal nodules Childhood‑
adolescence
Subependymal astrocytoma Childhood‑
adolescence
Single or multiple cardiac 
rhabdomyoma
Fetal stage
Lymphangioleiomyomatosis Adolescent‑adult
Renal angiomyolipoma Childhood‑adult
Minor Criteria
Multiple pits in dental enamel
Hamartomatous rectal polyps
Bone cysts
Cerebral white‑matter radial migration lines
Gingival fibromas
Nonrenal hamartomas
Retinal achromic patches
Confetti skin lesions
Multiple renal cysts
Definitive diagnosis: 2 major criteria or 1 major and 2 minor; probable: 
1 major and 1 minor; possible: 1 major and 2 or more minor
Figure. Angiofibromas on the cheeks, chin, and nose, with a 
predominant crazy paving pattern and bilateral distribution.
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were angiofibromas in 89.6%, followed by hypomelanotic 
macules in 58.2%, shagreen patches in 34.3%, Koenen 
tumors in 29.8%, and acrochordons in 8.95%. Fifteen of 
the 67 patients presented cardiac disorders, all of which 
were classed as rhabdomyoma (22.4%). Psychiatric 
disorders were present in 55.5% of the patients, in the form 
of mental retardation in 35.8% and behavioral disorders 
in 19.7%. All patients presented neurological disorders: 
67.2% were diagnosed with epilepsy and 46.2% presented 
tubers in imaging studies of the CNS. Renal disorders 
were present in 32.8%, angiomyolipomas in 25.3%, 
polycystic kidney disease in 6%, and renal cell carcinoma 
in 1 patient (1.5%). A total of 9 patients presented skeletal 
disorders: scoliosis in 7 (10.4%) and bone cysts in 2 (3%). 
Pulmonary disorders were observed in 9 patients: simple 
cysts in 7 (10.4%), an abscess in 1 (1.5%), and tuberculosis 
in 1 (1.5%). Ophthalmological disorders were diagnosed 
in 10 patients: retinal hamartomas in 7 (10.4%), and 
astrocytomas of the optic nerve in 3 (4.47%).
The dermatological disorders are summarized in 
Table 3. Angiofibroma was found in 60 patients and the 
most frequent location was on the cheeks (78.3%). To 
a lesser extent, they were located on the nose (48.3%), 
chin (33.3%), and on the nasogenian fold and forehead 
(13.3%). The most frequent presentation was crazy 
paving pattern in 80% and followed by a sebaceous 
pattern in 20%. The great majority were distributed 
bilaterally (98.33%), although 1 patient presented 
a unilateral distribution. Hypomelanotic macules 
appeared in 39 of the 67 patients. The most frequent 
shape was lanceolate or ash-leaf pattern (76.92%), 
followed by confetti pattern (51.28%), and fingerprint 
form (30.76%). A total of 40% of hypomelanotic macules 
could not be classified in any of the previous groups. 
The most typical location was on the anterior thorax 
(58.97%), legs (56.41%), arms (33.33%), posterior thorax 
(12.82%), and abdomen (10.25%). Koenen tumors were 
observed in 20 patients, with similar involvement of 
the hands (60%) and feet (55%). Sharkskin or shagreen 
patch was observed in 23 patients, mainly in the lumbar 
region (73.91%), although it also presented on the 
dorsal region (21.73%).
table 2.  Abnormalities Found in the Patients
Abnormality Type of Abnormality Frequency in Our Series Frequency in the Literature
Dermatological (100%) Angiofibromas 89.6% (n=60) 74.5%5‑83%1
Hypomelanotic macules 58.2% (n=39) 97.2%5
Shagreen patch 34.3% (n=23) 48.1%5‑54%1
Koenen tumor 29.8% (n=20) 68%1‑74.5%5
Acrochordons 8.95% (n=6) 22.6%5
Cardiac (22.4%) Cardiac rhabdomyomas 22.4% (n=15) 50‑70%6,7
Psychiatric (55.5%) Mental retardation 35.8% (n=24) 40‑50%8
Behavioral disorders 19.7% (n=12) 40‑50%8
Neurological (100%) Epilepsy 67.2% (n=43) 70‑80%5,9
CNS tubers 46.2% (n=31) 80%5,9
Renal (32.8%) Angiomyolipoma 25.3% (n=17) 55‑75%5,10
Polycystosis 6% (n=4) 3%5,10
Renal cell carcinoma 1.5% (n=1) 2‑3%5,10
Skeletal (13.4%) Scoliosis 10.4% (n=7) NS
Bone cysts 3% (n=2) NS
Pulmonary (13.4%) Pulmonary cysts 7% (n=7) 1‑26%11
Abscesses 1.5% (n=1) NS
Tuberculosis 1.5% (n=1) NS
Ophthalmological (11.9%) Astrocytoma of the optic nerve 1.5% (n=1) NS
Retinal hamartoma 10.4% (n=7) 40‑50%12
Abbreviations: CNS, central nervous system; NS, not specified.
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Discussion
The term tuberous sclerosis was coined in 1880 by 
Bourneville.13 In 1908, Vogt described the classic triad 
of mental retardation, epilepsy, and facial angiofibroma,14 
which is only present in 29% of the patients.1 Since then, 
several studies have been published which have assessed 
the frequency of the clinical manifestations of the disease. 
Based on what has been published up until present, a wide 
clinical spectrum of presentation has been identified. In 
the last decade, the discovery of the genes implicated in TS 
(TSC1 and TSC2), observations of Drosophila melanogaster 
models, the improved description of mosaicism, and the 
variable penetrance of the disease have helped answer 
the question of why some patients present minimal signs 
whereas others have serious disorders.
Diagnosis of TS is based on a series of major and minor 
criteria, since no single clinical criterion is of diagnostic 
value. The clinical manifestations of TS appear during 
different developmental periods (Table 1)4; thus, the 
validity of these criteria for early diagnosis is limited 
because some occur in late childhood or adolescence, 
and are further confounded by the numerous cases of 
atypical presentation. Thus, cardiac rhabdomyomas and 
cortical tubers appear during fetal development. Skin 
lesions are observed in 90% of patients of any age. The 
first to be detected are hypomelanotic macules in early 
childhood, whereas shagreen patch usually appears after 
the child is 5 years old. Facial angiofibromas can occur at 
any age, but mainly appear in late childhood. Periungual 
fibromas usually occur after puberty. Subependymal 
astrocytomas can develop in childhood and adolescence, 
renal angiomyolipomas in early childhood or adolescence, 
and lymphangioleiomyomatosis in late adolescent girls or 
adult women. The mean age of our sample was 27.6 years, 
suggesting that the great majority of skin manifestations 
had already appeared in these patients.
In our series, all patients presented dermatological 
disorders. Thus, conducting a detailed dermatological 
examination in patients with suspected TS is very cost-
effective, as well as being widely available and easy to 
perform. The most frequent finding in our patients was 
facial angiofibroma (89.6%), whereas in the reviewed 
literature hypomelanotic macules were the most frequent 
finding. In a series of 106 children with TS, Jòzwiak5 
observed hypomelanotic macules in 97.2%. In our group 
table 3. Description of the Dermatological Disorders
Angiofibromas 89.6 % (n = 60) Location Cheeks: 78.3% (n=47)
Nose: 48.3% (n=29)
Chin: 33.3% (n=20)
Nasogenian fold, forehead: 13.3% (n=8)
Presentation pattern Crazy paving: 80% (n=48)
Sebaceous: 20% (n=12
Distribution Bilateral: 98.33% (n=59)
Unilateral: 1.6% (n=1)
Hypomelanotic macules 58.2% (n= 39) Shape Lanceolate or ash‑leaf: 76.92% (n=30)
Confetti: 51.28% (n=20)
Fingerprint: 30.76% (n=12)
Other: 40% (n=24)
Location Anterior thorax: 58.97% (n=23)
Legs: 56.41% (n=22)
Arms: 33.33% (n=13)
Posterior thorax: 12.82% (n=5)
Abdomen: 10.25% (n=4)
Koenen tumors 29.8% (n=20) Location Hands: 60% (n=12)
Feet: 55% (n=11)
Shagreen patch 34.3% (n= 23) Location Lumbar: 73.91% (n=17)
Posterior trunk: 21.73% (n=5)
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of patients, these appeared in 58.2%. We observed 
shagreen patch in 34.3%, with frequencies similar to those 
reported in the literature (48%-54%).1,5 However, the 
frequency of Koenen tumors and acrochordons was less 
than that described in the literature (29.8% and 8.95%, 
respectively).
No detailed study of the dermatological lesions appears 
in the reviewed literature. In our sample, the most 
frequent form of presentation of angiofibroma was on the 
cheeks (78.3%), with a crazy paving pattern (80%) and 
bilateral location (98.33%). Other less frequent locations 
were the nose (48.3%) and chin (33.3%). One patient 
presented lesions with a unilateral distribution, probably 
as a segmental type I manifestation of mosaicism,15 since 
all the patients were formally diagnosed with TS. These 
skin lesions cause patients severe esthetic, psychological, 
and medical problems. The current treatment of choice 
for angiofibroma is laser therapy, since it provides the 
most selective form of lesion destruction, minimizing 
residual thermal damage and, thus, adverse effects. The 
treatment of choice for angiofibroma with a high fibrous 
component or for protruding angiofibroma is carbon 
dioxide laser therapy administered in different modes. 
In a recently published retrospective study conducted 
in our center,  the long-term results of carbon dioxide 
laser treatment (continuous and superpulsed modes) for 
angiofibromas were assessed.16 That study demonstrated a 
high percentage of recurrences (60.9%), despite the good 
and even excellent initial outcomes. Recurrences occurred 
earlier when the patients were treated before reaching 20 
years of age.
The most frequent type of hypomelanotic macules 
were ash-leaf shaped (76.92%), as described in the 
classic form of the disease. Confetti pattern (51.28%) 
and fingerprint forms (30.76%) were less common. A 
total of 40% of macules could not be classified into any 
of the previous forms, once again indicating the clinical 
variability of this disease. The most common location 
was on the anterior thorax and arms and legs. Koenen 
tumors were almost equally distributed between the 
hands and feet (60% and 55%, respectively). Shagreen 
patch was most frequently located in the lumbar region 
(73.91%) as described in the classic texts; however, some 
were located in upper areas of the body, such as the 
posterior trunk (21.3%).
As was the case for dermatological disorders, all 
patients in our series presented neurological disorders. 
These are the leading cause of morbidity and mortality 
in patients with TS and include epilepsy and findings 
of cortical tubers detected by neuroimaging techniques 
(computerized tomography [CT] or magnetic 
resonance imaging [MRI]). These 2 findings are closely 
linked as tubers are the cause of the seizures. Tubers 
are developmental disorders of the cerebral cortex. 
Histological study shows that its normal organization 
into 6 layers is lost and abnormally-shaped neurons, 
large astrocytes, and a special type of cell known as a 
giant cell can be observed.17 These persist throughout 
life and are benign, except for any direct symptoms that 
may arise. According to the literature, up to 70%-80% 
of patients with TS present epilepsy5,9 and 80% present 
cortical tubers.5,9 The percentages are again lower in our 
series of patients, with epilepsy diagnosed in 67.2% and 
findings of tubers in the CNS in 46.2%.
The third most prevalent disorder was psychiatric 
and affected 55.5% of the patients. Mental retardation 
was diagnosed in 35.8% and almost 20% had behavioral 
disorders. In the literature, these percentages are as high 
as 40%-50%8; however, these figures pool patients with 
psychological disorders and those with mental retardation 
in general, rather than treating them separately as we did. 
These types of disorder are also closely associated with 
the presence of cortical tubers, especially those located in 
the forebrain. The behavioral disorder most frequently 
associated with TS was autism.5
Specific renal disorders are found in close association 
with TS. Angiomyolipoma is the most frequent 
manifestation, since it appears in 55%-75% of the 
patients. Angiomyolipomas are benign tumors made up 
of abnormal vessels, immature smooth muscle cells, and 
fat cells. In some patients with TS, these are bilateral and 
multiple.10 They are detected by echography, CT, or MRI. 
Their main complication, especially in those larger than 
3 cm, is bleeding.5,10 This was detected in 25.3% of our 
patients. Other findings were polycystic kidney disease 
in 6% (3% in the literature) and renal cell carcinoma in 
1.5% (2%-3% in the literature). The incidence of renal cell 
carcinoma in the general population is similar to that of 
patients with TS, although this is usually diagnosed in the 
latter group at earlier ages.10
Cardiac rhabdomyoma is an intracavitary or intramural 
tumor that has been detected in 50%-70% of patients, but 
leads to a far lower percentage of problems among them. 
It usually presents as heart failure during childhood and 
as tachyarrhythmias. It is one of the first manifestations 
of TS and can be detected in utero, and is one of the 
main prenatal diagnostic markers of TS. In addition, it 
is the most frequently detected cardiac tumor during the 
neonatal period.7 This was found in a lower percentage 
(22.4%) of our patients.
The most commonly associated pulmonary lesion 
is lymphangioleiomyomatosis, and appears in women 
affected by TS in the second or third decade of life. It 
is characterized by smooth muscle cell proliferation 
leading to pulmonary cyst formation and pneumothorax. 
It worsens during pregnancy and with the administration 
of estrogens.5,18 In the literature, it appears in 57% of the 
patients affected with TS,11 whereas in our series it was 
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diagnosed in only 7%. It was only studied in clinical cases 
in our group, and thus patients presenting subclinical 
changes were not identified.  This fact may explain the 
lower percentages found in our study.
Retinal hamartomas are the ocular disorders most 
frequently associated with TS and appear in 40%-50% 
of patients. They remain stable and asymptomatic during 
the patient’s lifetime.12 In our series, a lower percentage of 
10.4% was observed, perhaps due to the low mean age of 
our patients (27 years), given that the incidence of retinal 
hamartomas increases with age.
In general, in our series of patients, there were fewer 
clinical findings than those reported in the reviewed 
literature. This could be due to the limitations of the 
study itself (retrospective study, the inclusion method, 
and the low number of patients). On the other hand, 
in clinical terms, TS is a highly polymorphic disease 
that includes a broad spectrum of disorders, ranging 
from very mild cases to severe ones, and with variable 
expression over time—observations which could explain 
the different percentages found. Nevertheless, our series 
constitutes research conducted in clinical practice, and 
the patients, with specific disorders, were not studied in 
the same manner, since the complementary tests were 
determined by the symptoms present. However, if the 
associated disorders in our series of patients and those in 
the reviewed literature (Table 4) are ordered by frequency, 
the observed differences are minimal, confirming that at 
least the relative orders tally.
We report the clinical findings in a series of patients 
with TS and compare them to previously published 
findings. Few studies of this type have been conducted, 
and the present study is the first one conducted in a 
Spanish population. Overall, our findings support those 
already published, although some small differences were 
observed.
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